Interleukin-1 Alters Glutamate Transmission at Purkinje Cell Synapses in a Mouse Model of Multiple Sclerosis
Georgia Mandolesi(Vita-Salute San Raffaele University), Diego Centonze(University of Rome Tor Vergata)
Cited by 188
Related Papers
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
|Journal of Neurology|2022|187
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
|The Lancet Neurology|2019|185
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis
|Frontiers in Cellular Neuroscience|2020|77
Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
|Journal of Neurology|2021|55